← FDA Drug Approvals (Drugs@FDA)

CARBIDOPA AND LEVODOPA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2021-10-05

Drug application

FDA Application #

ANDA214091

Application type

Abbreviated New Drug Application (Generic)

Brand name

CARBIDOPA AND LEVODOPA

Generic name

CARBIDOPA AND LEVODOPA

Active ingredients

CARBIDOPA; LEVODOPA

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

Radha Pharmaceuticals Inc

First approval

2021-10-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown